NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Xenex LightStrike™ Germ-Zapping Robots™

Disinfection technology has taken a leap forward with Xenex LightStrike™ Germ-Zapping Robots™. Providing safe and efficient OR disinfection via intense pulsed xenon UV light, LightStrike robots are utilized for terminal cleans, yet fast enough for between case cleaning too. A recent study conducted at MD Anderson Cancer Center found that a 2-minute cycle of pulsed xenon UV eliminated 72% more pathogens on high-touch surface areas in the OR than manual cleaning alone. Proven effective in 9 HAI reduction studies, LightStrike robots are the only UV disinfection technology credited by hospitals in peer-reviewed, published studies for helping them reduce their SSI rates by 46-100%.

For more information, visit www.xenex.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X